carbachol has been researched along with Cranial Nerve II Diseases in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After laser treatment, intraocular pressure (IOP) was elevated 1." | 1.36 | Altered calcium signaling in an experimental model of glaucoma. ( Akerman, KE; Kaarniranta, K; Kalesnykas, G; Larsson, KP; Niittykoski, M; Uusitalo, H, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niittykoski, M | 1 |
| Kalesnykas, G | 1 |
| Larsson, KP | 1 |
| Kaarniranta, K | 1 |
| Akerman, KE | 1 |
| Uusitalo, H | 1 |
1 other study available for carbachol and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Altered calcium signaling in an experimental model of glaucoma.
Topics: Adenosine Triphosphate; Animals; Axons; Calcium; Calcium Signaling; Carbachol; Cholinergic Agonists; | 2010 |